INS and Hypoglycemia: • Limit the use of insulin to the sole basal insulin as long as possible, both in waitlisted and in post-LTx patients, to reduce the risk of hypoglycemia and sustain quality of life. The association of basal insulin and GLP-1RAs may be a feasible alternative to intensified insulin treatment.